Edited by:
Professor Zhenshu Xu, MD, PhD, Fujian Medical University Union Hospital, China
Experimental Hematology & Oncology is calling for submissions to our Collection on 'New developments in CAR T, CAR NK, and CAR macrophage cell therapies.'
Experimental Hematology & Oncology is calling for submissions to our Collection on 'New developments in CAR T, CAR NK, and CAR macrophage cell therapies.' CAR engineered cell therapies are moving rapidly from bench to bedside. This collection welcomes studies covering the latest development in pre-clinical and clinical studies of CAR -engineered cell therapies.
Image credits: © Meletios Verras / Getty Images / iStock
There are currently no articles in this collection.
This Collection welcomes submission of Research Articles and Reviews. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal.
Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “New developments in CAR T, CAR NK, and CAR macrophage cell therapies" under the “Details” tab during the submission stage. Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.
Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.
The Guest Editor has no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editor has competing interests is handled by another Editorial Board Member who has no competing interests.